Evidence map›Paper›PMID 28604445›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2017

Development of an HIV Testing Dashboard to Complement the HIV Care Continuum Among MSM, PWID, and Heterosexuals in Washington, DC, 2007-2015.

Rudy Patrick, Alan Greenberg, Manya Magnus, Jenevieve Opoku, Michael Kharfen, Irene Kuo

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. HIV Testing Program Activities and Challenges in Four U.S. Urban Areas.AIDS education and prevention : official publication of the International Society for AIDS Education · 2022
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rudy Patrick*Department of Epidemiology & Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, DC; and †District of Columbia Department of Health, HIV/AIDS, Hepatitis, STD, and TB Administration, Washington, DC.
Alan Greenberg
Manya Magnus
Jenevieve Opoku
Michael Kharfen
Irene Kuo
Milken Institute · USGeorge Washington University · US

Funding

SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
NATIONAL HIV BEHAVIORAL SURVEILLANCE IN THE DISTRICT OF COLUMBIAU1BPS003261 · PS · DC DEPARTMENT OF HEALTH · PI OPOKU, JENEVIEVE · 2011 to 2015
$2.5M
National HIV Behavioral Surveillance, District of ColumbiaU62PS005093 · PS · GOVERNMENT OF THE DISTRICT OF COLUMBIA · PI OPOKU, JENEVIEVE · 2016 to 2016
$104k
NCHHSTP CDC HHS U1B PS003261NCHHSTP CDC HHS U62 PS005093NIAID NIH HHS P30 AI117970
6 · The paper itself

Abstract

backgroundWe developed an HIV testing dashboard to complement the HIV care continuum in selected high-risk populations. Using National HIV Behavioral Surveillance (NHBS) data, we examined trends in HIV testing and care for men who have sex with men (MSM), persons who inject drugs (PWID), and heterosexuals at elevated risk (HET).

methodsBetween 2007 and 2015, 4792 participants ≥18 years old completed a behavioral survey and were offered HIV testing. For the testing dashboard, proportions ever tested, tested in the past year, testing HIV-positive, and newly testing positive were calculated. An abbreviated care continuum for self-reported positive (SRP) persons included ever engagement in care, past year care, and current antiretroviral (ARV) use. The testing dashboard and care continuum were calculated separately for each population. Chi-square test for trend was used to assess significant trends over time.

resultsAmong MSM, lifetime HIV testing and prevalence significantly increased from 96% to 98% (P = 0.01) and 14%-20% (P = 0.02) over time; prevalence was highest among black MSM at all time points. HIV prevalence among female persons who inject drugs was significantly higher in 2015 vs. 2009 (27% and 13%; P < 0.01). Among heterosexuals at elevated risk from 2010 to 2013, annual testing increased significantly (45%-73%; P < 0.001) and the proportion newly diagnosed decreased significantly (P < 0.01). Self-reported positive MSM had high levels of care engagement and antiretroviral use; among self-reported positive persons who inject drugs and heterosexuals at elevated risk, past year care engagement and antiretroviral use increased over time.

conclusionsThe HIV testing dashboard can be used to complement the HIV care continuum to display improvements and disparities in HIV testing and care over time.

Indexed as

HeterosexualityHomosexuality, MaleTransgender PersonsAdultBehavioral Risk Factor Surveillance SystemContinuity of Patient CareDistrict of ColumbiaFemaleHIV InfectionsHumansMaleMiddle AgedPrevalenceRisk AssessmentRisk-TakingSubstance Abuse, Intravenous

Identifiers

PMID28604445
PMCPMC5884696
OpenAlexW2621861609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.